Brief: SMS Lifesciences India Executes Share Purchase, Share-Subscription Agreements With Chemwerth Inc USA
Dec 14 (Reuters) - SMS Lifesciences India Ltd SMSL.NS :
* TO SELL UPTO 10% OF SHAREHOLDING IN MAHI DRUGS
* EXECUTED SHARE PURCHASE AGREEMENT, SHARE-SUBSCRIPTION
AGREEMENT
WITH CHEMWERTH INC USA
Source text for Eikon: ID:nBSE1y5ZTZ
Further company coverage: SMSL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls